Nitric Oxide Synthase: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 108: Line 108:
== Additional 3D Structures of Nitric Oxide Synthase ==
== Additional 3D Structures of Nitric Oxide Synthase ==


''Update June 2011''
''Updated December 2011''


'''Nitric Oxide Synthase''' (NOS) is an enzyme which catalyzes the production of the signaling molecule NO from arginine.  In mammals, NOS appears as 3 isozymes: neuronal NOS (nNOS), cytokine-inducible NOS (iNOS) and endothelial NOS (eNOS).  The N-terminal domain of NOS is an oxygenase domain (OD).  NOS cofactors are: NADPH, FAD, FMN, heme and O2. <br />
'''Nitric Oxide Synthase''' (NOS) is an enzyme which catalyzes the production of the signaling molecule NO from arginine.  In mammals, NOS appears as 3 isozymes: neuronal NOS (nNOS), cytokine-inducible NOS (iNOS) and endothelial NOS (eNOS).  The N-terminal domain of NOS is an oxygenase domain (OD).  NOS cofactors are: NADPH, FAD, FMN, heme and O2. <br />
Line 117: Line 117:
===Endothelial NOS===
===Endothelial NOS===


[[3nld]], [[3nle]], [[3nlf]], [[3nlg]], [[3jww]], [[3jwx]], [[3jwy]], [[3jwz]], [[3dqs]], [[3dqt]] – b-eNOS OD+pyrrolidinomethyl aminopyridine derivative – bovine<br />
[[3nld]], [[3nle]], [[3nlf]], [[3nlg]], [[3jww]], [[3jwx]], [[3jwy]], [[3jwz]], [[3dqs]], [[3dqt]], [[3pnh]] – b-eNOS OD+pyrrolidinomethyl pyridine derivative – bovine<br />
[[1dm6]] – b-eNOS OD+guanidine derivative<br />
[[1dm6]] – b-eNOS OD+guanidine derivative<br />
[[3nlh]] – b-eNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative<br />
[[3nlh]] – b-eNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative<br />
[[3e7s]] – b-eNOS OD+inhibitor<br />
[[1rs8]], [[1rs9]], [[1p6n]] – b-eNOS OD +dipeptide inhibitor<br />
[[1rs8]], [[1rs9]] – b-eNOS OD +dipeptide inhibitor<br />
[[1nse]] – b-eNOS OD<br />
[[1nse]] – b-eNOS OD<br />
[[1p6n]] – b-eNOS OD +dipeptide inhibitor<br />
[[1p6n]] – b-eNOS OD +dipeptide inhibitor<br />
Line 129: Line 128:
[[1i83]], [[1d1v]], [[1d1x]], [[1d1y]], [[1ed4]], [[9nse]] – b-eNOS OD+urea derivative<br />
[[1i83]], [[1d1v]], [[1d1x]], [[1d1y]], [[1ed4]], [[9nse]] – b-eNOS OD+urea derivative<br />
[[1dmj]], [[1dmk]] – b-eNOS OD+pterin derivative<br />
[[1dmj]], [[1dmk]] – b-eNOS OD+pterin derivative<br />
[[1foi]], [[1dmi]], [[1i83]], [[3n5p]], [[3n5q]], [[3n5r]], [[3n5s]], [[3n5t]], [[3n5v]], [[3n5w]], [[3n5x]], [[3n5y]], [[3n5z]], [[3n60]], [[3n61]], [[3n62]], [[3n63]], [[3n64]], [[3n65]], [[3n66]], [[3n67]], [[3n68]], [[3n69]], [[3n6a]], [[3n6b]], [[3n6c]], [[3n6d]], [[3n6e]], [[3n6f]], [[3n6g]], [[3nlt]], [[3nlu]] – b-eNOS OD+inhibitor<br />
[[1foi]], [[1dmi]], [[1i83]], [[3n5p]], [[3n5q]], [[3n5r]], [[3n5s]], [[3n5t]], [[3n5v]], [[3n5w]], [[3n5x]], [[3n5y]], [[3n5z]], [[3n60]], [[3n61]], [[3n62]], [[3n63]], [[3n64]], [[3n65]], [[3n66]], [[3n67]], [[3n68]], [[3n69]], [[3n6a]], [[3n6b]], [[3n6c]], [[3n6d]], [[3n6e]], [[3n6f]], [[3n6g]], [[3nlt]], [[3nlu]], [[3e7s]] – b-eNOS OD+inhibitor<br />
[[1d0c]], [[8nse]], [[1foj]], [[1ed5]] – b-eNOS OD+indazole derivative<br />
[[1d0c]], [[8nse]], [[1foj]], [[1ed5]], [[1d0o]], [[1d1w]] – b-eNOS OD+indazole derivative<br />
[[1dm8]] – b-eNOS OD+triazole derivative<br />
[[1dm8]] – b-eNOS OD+triazole derivative<br />
[[1ed6]] – b-eNOS OD+NO<br />
[[1ed6]] – b-eNOS OD+NO<br />
Line 139: Line 138:
[[1m9j]] – h-eNOS OD+chlorzoxazone<br />
[[1m9j]] – h-eNOS OD+chlorzoxazone<br />
[[1m9k]], [[1m9r]] – h-eNOS OD+indazole derivative<br />
[[1m9k]], [[1m9r]] – h-eNOS OD+indazole derivative<br />
[[1nsi]] - h-eNOS OD+ Zn


===Neuronal NOS===
===Neuronal NOS===
Line 146: Line 146:
[[3nli]], [[3nlj]], [[3nlk]], [[3nln]], [[3nlo]], [[3nlp]], [[3nlq]], [[3nlr]], [[3jws]], [[3jwt]], [[3jwu]], [[3jwv]], [[3jx0]], [[3jx1]], [[3jx2]], [[3jx3]], [[3jx4]], [[3jx5]], [[3jx6]], [[3dqr]] – r-nNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative – rat<br />
[[3nli]], [[3nlj]], [[3nlk]], [[3nln]], [[3nlo]], [[3nlp]], [[3nlq]], [[3nlr]], [[3jws]], [[3jwt]], [[3jwu]], [[3jwv]], [[3jx0]], [[3jx1]], [[3jx2]], [[3jx3]], [[3jx4]], [[3jx5]], [[3jx6]], [[3dqr]] – r-nNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative – rat<br />
[[3nlm]], [[3nny]], [[3nnz]], [[3n2r]], [[3b3o]], [[3b3p]], [[3b3m]], [[3b3n]] – r-nNOS OD+pyrrolidinomethyl aminopyridine derivative<br />
[[3nlm]], [[3nny]], [[3nnz]], [[3n2r]], [[3b3o]], [[3b3p]], [[3b3m]], [[3b3n]] – r-nNOS OD+pyrrolidinomethyl aminopyridine derivative<br />
[[3pne]], [[3pnf]], [[3png]], [[3svp]], [[3svq]] – r-nNOS OD+pyrrolidinomethyl methylpyridine derivative<br />
[[2hx3]] – r-nNOS OD+nitroguanidine derivative<br />
[[2hx3]] – r-nNOS OD+nitroguanidine derivative<br />
[[2hx4]], [[1zvl]] – r-nNOS OD+arginine derivative<br />
[[2hx4]], [[1zvl]] – r-nNOS OD+arginine derivative<br />
Line 153: Line 154:
[[1lzz]], [[1m00]] – r-nNOS OD+guanidine derivative<br />
[[1lzz]], [[1m00]] – r-nNOS OD+guanidine derivative<br />
[[3fc5]], [[1zvi]] – r-nNOS OD<br />
[[3fc5]], [[1zvi]] – r-nNOS OD<br />
[[1qau]] - r-nNOS OD PDZ domain<br />
[[1qav]] - r-nNOS OD PDZ domain + α-1 syntrophin<br />
[[1qw6]] – r-nNOS OD+arginine derivative<br />
[[1qw6]] – r-nNOS OD+arginine derivative<br />
[[1qwc]], [[3q99]], [[3q9a]] – r-nNOS OD+inhibitor<br />
[[1qwc]], [[3q99]], [[3q9a]] – r-nNOS OD+inhibitor<br />
Line 170: Line 173:
===Inducible NOS===
===Inducible NOS===
   
   
[[3nqs]], [[3e65]] – m-iNOS OD + pterin derivative<br />  
[[3nqs]], [[3e65]], [[3eai]], [[3ebd]], [[3ebf]], [[1r35]], [[2nod]]  – m-iNOS OD + pterin derivative<br />  
[[1jwj]], [[1jwk]] – m-iNOS OD (mutant)+ pterin derivative<br />
[[1jwj]], [[1jwk]] – m-iNOS OD (mutant)+ pterin derivative<br />
[[2bhj]] – m-iNOS OD+coumarin<br />
[[2bhj]] – m-iNOS OD+coumarin<br />
[[3eai]], [[3ebd]], [[3ebf]], [[1r35]], [[2nod]] – m-iNOS OD+pterin derivative<br />
[[3nod]] – m-iNOS OD+product analog<br />
[[3nod]] – m-iNOS OD+product analog<br />
[[1noc]] – m-iNOS OD+chloramphenicol acetyltransferase<br />
[[1noc]] – m-iNOS OD+chloramphenicol acetyltransferase<br />
[[3e67]] – m-iNOS OD+4-MAP<br />
[[3e67]] – m-iNOS OD+4-MAP<br />
[[3e68]], [[3e6l]], [[3e6n]], [[3e6o]], [[3e6t]], [[3e7i]], [[3e7m]], [[3e7t]], [[1vaf]], [[1qw5]], [[1dd7]], [[2y37]] – m-iNOS OD+inhibitor <br />
[[3e68]], [[3e6l]], [[3e6n]], [[3e6o]], [[3e6t]], [[3e7i]], [[3e7m]], [[3e7t]], [[1vaf]], [[1qw5]], [[1dd7]], [[2y37]] – m-iNOS OD+inhibitor <br />
[[2orq]], [[2orr]], [[2ors]], [[2ort]], [[2oro]], [[2orp]], [[1nos]] – m-iNOS OD+imidazole derivative<br />
[[2orq]], [[2orr]], [[2ors]], [[2ort]], [[2oro]], [[2orp]], [[1nos]], [[3nw2]] – m-iNOS OD+imidazole derivative<br />
[[1df1]] - m-iNOS OD+ urea derivative<br />
[[3dwj]] – m-iNOS OD (mutant)<br />
[[3dwj]] – m-iNOS OD (mutant)<br />
[[1qom]] - m-iNOS OD<br />
[[1qw4]], [[1dwv]], [[1dww]], [[1dwx]], [[1nod]] – m-iNOS OD+arginine derivative<br />
[[1qw4]], [[1dwv]], [[1dww]], [[1dwx]], [[1nod]] – m-iNOS OD+arginine derivative<br />
[[2nos]] – m-iNOS OD+guanidine derivative<br />
[[2nos]] – m-iNOS OD+guanidine derivative<br />

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michael Skovbo Windahl, Sara Toftegaard Petersen, Mathilde Thomsen, Mette Trauelsen, Eran Hodis, Jaime Prilusky, Karl Oberholser, Alexander Berchansky, Michal Harel, Ann Taylor